Glucose tolerance and insulin response in normal-weight and obese cats.
Glucose tolerance and insulin response were evaluated in 9 normal-weight and 6 obese cats after IV administration of 0.5 g of glucose/kg of body weight. Blood samples for glucose and insulin determinations were collected immediately prior to and 2.5, 5, 7.5, 10, 15, 30, 45, 60, 90, and 120 minutes after glucose infusion. Baseline glucose concentrations were not significantly different between normal-weight and obese cats; however, mean +/- SEM glucose tolerance was significantly impaired in obese vs normal-weight cats after glucose infusion (half time for glucose disappearance in serum--77 +/- 7 vs 51 +/- 4 minutes, P less than 0.01; glucose disappearance coefficient--0.95 +/- 0.10 vs 1.44 +/- 0.10%/min, P less than 0.01; insulinogenic index--0.20 +/- 0.02 vs 0.12 +/- 0.01, P less than 0.005, respectively). Baseline serum insulin concentrations were not significantly different between obese and normal-weight cats. Insulin peak response after glucose infusion was significantly (P less than 0.005) greater in obese than in normal-weight cats. Insulin secretion during the first 60 minutes (P less than 0.02), second 60 minutes (P less than 0.001), and total 120 minutes (P less than 0.0003) after glucose infusion was also significantly greater in obese than in normal-weight cats. Most insulin was secreted during the first hour after glucose infusion in normal-weight cats and during the second hour in obese cats. The impaired glucose tolerance and altered insulin response to glucose infusion in the obese cats was believed to be attributable to deleterious effects of obesity on insulin action and beta-cell responsiveness to stimuli (ie, glucose).
Department of Medicine, School of Veterinary Medicine, University of California, Davis 95616.
R W
RW
Nelson
C A
CA
Himsel
E C
EC
Feldman
G D
GD
Bottoms
D000818:Animals; D001786:Blood Glucose; D002371:Cat Diseases / Q000097:blood*; D002415:Cats; D005260:Female; D005934:Glucagon / Q000008:administration & dosage / Q000494:pharmacology; D005951:Glucose Tolerance Test / Q000379:methods / Q000662:veterinary; D007262:Infusions, Intravenous / Q000662:veterinary; D007328:Insulin / Q000097:blood* / Q000378:metabolism; D000078790:Insulin Secretion; D008297:Male; D009765:Obesity / Q000097:blood / Q000662:veterinary*; D011863:Radioimmunoassay / Q000662:veterinary; D013997:Time Factors
D001786:Blood Glucose; D007328:Insulin; D005934:Glucagon